Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Abbott to acquire Cardiovascular Systems for $837.6 mln
The deal will help Abbott gain access to CSI's minimally invasive device to treat blocked arteries.
Chicago: Abbott Laboratories said on Wednesday it had agreed to acquire medical device maker Cardiovascular Systems Inc (CSI) for $837.6 million. On a per-share basis, the medical device maker has offered $20, a 50.3 per cent premium to the last closing price of CSI stock.The deal will help Abbott gain access to CSI's minimally invasive device to treat blocked arteries.
Abbott said the transaction is expected to be neutral to its recently issued 2023 ongoing earnings forecast.